WO2006135904A3 - Procede permettant d'obtenir de meilleurs resultats pour des applications qui utilisent directement ou indirectement des resultats de dosage d'expression genetique - Google Patents

Procede permettant d'obtenir de meilleurs resultats pour des applications qui utilisent directement ou indirectement des resultats de dosage d'expression genetique Download PDF

Info

Publication number
WO2006135904A3
WO2006135904A3 PCT/US2006/023046 US2006023046W WO2006135904A3 WO 2006135904 A3 WO2006135904 A3 WO 2006135904A3 US 2006023046 W US2006023046 W US 2006023046W WO 2006135904 A3 WO2006135904 A3 WO 2006135904A3
Authority
WO
WIPO (PCT)
Prior art keywords
results
applications
directly
gene expression
expression assay
Prior art date
Application number
PCT/US2006/023046
Other languages
English (en)
Other versions
WO2006135904A2 (fr
Inventor
David E Kohne
Original Assignee
David E Kohne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David E Kohne filed Critical David E Kohne
Publication of WO2006135904A2 publication Critical patent/WO2006135904A2/fr
Publication of WO2006135904A3 publication Critical patent/WO2006135904A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé permettant d'obtenir de meilleurs résultats pour des applications de tout genre qui utilisent directement ou indirectement des résultats de dosage d'expression génétique.
PCT/US2006/023046 2005-06-13 2006-06-13 Procede permettant d'obtenir de meilleurs resultats pour des applications qui utilisent directement ou indirectement des resultats de dosage d'expression genetique WO2006135904A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68998505P 2005-06-13 2005-06-13
US60/689,985 2005-06-13

Publications (2)

Publication Number Publication Date
WO2006135904A2 WO2006135904A2 (fr) 2006-12-21
WO2006135904A3 true WO2006135904A3 (fr) 2009-04-30

Family

ID=37532908

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/023046 WO2006135904A2 (fr) 2005-06-13 2006-06-13 Procede permettant d'obtenir de meilleurs resultats pour des applications qui utilisent directement ou indirectement des resultats de dosage d'expression genetique

Country Status (1)

Country Link
WO (1) WO2006135904A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027714A2 (fr) 2003-07-12 2005-03-31 Accelr8 Technology Corporation Biodetection sensible et rapide
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
SG10201704689XA (en) * 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
FI20105252A0 (fi) 2010-03-12 2010-03-12 Medisapiens Oy Menetelmä, järjestely ja tietokoneohjelmatuote biologisen tai lääketieteellisen näytteen analysoimiseen
CA3007713C (fr) * 2010-04-29 2020-05-26 The Regents Of The University Of California Algorithme de reconnaissance de voie a l'aide d'integration de donnees sur des modeles genetiques (paradigme)
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
EP2683831B1 (fr) 2011-03-07 2015-09-23 Accelerate Diagnostics, Inc. Systèmes de purification rapide de cellules
WO2013010074A1 (fr) 2011-07-13 2013-01-17 Primeradx, Inc. Méthodes multimodales de détection et de quantification simultanées de plusieurs acides nucléiques dans un échantillon
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
AU2016243656A1 (en) 2015-03-30 2017-11-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
CN110019155B (zh) * 2017-09-30 2023-04-07 山西医科大学 microRNA组学数据扰动平台
WO2019071007A1 (fr) * 2017-10-05 2019-04-11 New York Genome Center, Inc. Procédés et compositions pour le ciblage du mimétisme vasculaire
CN109683059B (zh) * 2018-12-30 2021-06-22 国网北京市电力公司 确定线损异常的方法及装置、存储介质、处理器
US11170872B2 (en) 2019-11-05 2021-11-09 Apeel Technology, Inc. Prediction of latent infection in plant products
CN113130010A (zh) * 2021-04-22 2021-07-16 中山大学 一种基因调控网络数据库及其在个性化药物筛选中的应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIM ET AL.: "Microarray Analysis Shows that Some microsRNAs Downregulate Large Numbers of Target mRNAs", NATURE, vol. 433, February 2005 (2005-02-01), pages 769 - 773 *
QUACKENBUSH, JOHN: "Microarray Data Normalization and Transformation", NATURE GENETICS SUPPLEMENT, vol. 32, 2002, pages 496 - 501 *
YANG ET AL.: "Normalization for cDNA Microarray Data: a Robust Composite Method Addressing Single and Multiple Slide Systemic Variation", NUCLEIC ACIDS RESEARCH, vol. 30, no. 4, 2002, pages E15 *

Also Published As

Publication number Publication date
WO2006135904A2 (fr) 2006-12-21

Similar Documents

Publication Publication Date Title
WO2006135904A3 (fr) Procede permettant d'obtenir de meilleurs resultats pour des applications qui utilisent directement ou indirectement des resultats de dosage d'expression genetique
WO2007008583A3 (fr) Resultats et application ameliores d'epreuves de comparaison d'expressions proteiniques
WO2008033575A3 (fr) Procédés d'identification de cheminements biochimiques
WO2006089125A3 (fr) Méthodes de détection du cancer de l'ovaire
EP2005155A4 (fr) Assemblage de chambre microfluidique pour test de mammite
EG25147A (en) Process for the manufacture of 1,2-dichloroethane.
WO2008091954A3 (fr) Anticorps cd40 optimisés et leurs procédés d'utilisation
MX291201B (es) Produccion fermentativa de compuestos quimicos finos.
EP2035398B8 (fr) 1,2-benzisothiazolin-3-one immobilisée
WO2007139849A3 (fr) Nanomatrices d'acides nucléiques modifiés et leurs utilisations
WO2009075554A3 (fr) Procédé et système permettant de fournir des informations sur les brevets
WO2007014197A3 (fr) Vecteurs d'expression de levures pour la production du facteur itf
AU2009312751A8 (en) A screening assay for insecticides
WO2008043543A3 (fr) Balises d'acides nucleiques pour l'hybridation in situ en fluorescence et technologie a puces
WO2008051860A3 (fr) Anodisation
AP2270A (en) Bioleaching process control.
WO2009025761A3 (fr) Procédés pour identifier des souches bactériennes qui produisent de la l-tyrosine
PT1955066E (pt) Método de ensaio em membrana
WO2006135677A3 (fr) Analyse de poissons zebres
WO2007149896A3 (fr) Dosage de fragmentation d'adn
WO2007140540A3 (fr) Identification d'une molécule d'acide nucléique
WO2007063556A3 (fr) Processus industriel ameliore pour la preparation de chlorhydrate d'alfuzosine et de ses nouveaux polymorphes
GB0502065D0 (en) Assay method
WO2006116687A3 (fr) Nanodosages
WO2007095405A3 (fr) modification de données

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006784841

Country of ref document: EP

122 Ep: pct application non-entry in european phase

Ref document number: 06784841

Country of ref document: EP

Kind code of ref document: A2